«A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF TARLATAMAB COMPARED WITH STANDARD OF CARE IN SUBJECTS WITH RELAPSED SMALL CELL LUNG CANCER AFTER PLATINUM-BASED FIRST-LINE CHEMOTHERAPY (DELLPHI-304) »

ΜΗ ΕΝΕΡΓΟ RECRUITMENT Έναρξη Μελέτης: Οκτ-23 Λήξη Μελέτης: Μαϊ-08